Mathieu Clavel

Mathieu Clavel is a research assistant currently employed at Light Chain Bioscience and Novimmune SA since May 2023, with previous research assistant experience at AC Immune (March 2022 - May 2023) and Light Chain Bioscience and Novimmune SA (March 2021 - March 2022). Mathieu Clavel has a solid academic background from Université Grenoble Alpes, holding a Master 2 degree in Médicaments Biotechnologiques and a Master 1 degree in Sciences et Management des biotechnologies, alongside a Licence in Biotechnologie pour la santé obtained between 2017 and 2019. Participation in the International Genetically Engineered Machine (iGEM) Competition resulted in the PyoBusters project, which focused on engineering E. coli for specific applications.